CFTR and cystic fibrosis: In summary, our data provide a strong basis for improvement of DNA diagnostics of CF, foster provision of reproductive choice in preconception‐, preimplantation‐, and/or prenatal DNA testing, facilitate the introduction of multitier CFNBS and eventually will provide patient stratification for the implementation of CFTR modulator therapy (Mitchell, Jones, & Barry, 2018).